Cargando…

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

BACKGROUND: Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Sten, Mischak, Harald, Zürbig, Petra, Parving, Hans-Henrik, Rossing, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988775/ https://www.ncbi.nlm.nih.gov/pubmed/21040538 http://dx.doi.org/10.1186/1471-2369-11-29

Ejemplares similares

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
por: Currie, Gemma E., et al.
Publicado: (2018)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review
por: Persson, Frederik, et al.
Publicado: (2016)

Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes
por: Magalhães, Pedro, et al.
Publicado: (2020)

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
por: Gæde, Peter, et al.
Publicado: (2016)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
por: Oellgaard, Jens, et al.
Publicado: (2018)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria
por: Poulsen, Christina Gjerlev, et al.
Publicado: (2023)

Urinary Proteome Differences in Canine Diabetes with and without the Presence of Microalbuminuria
por: Winiarczyk, Dagmara, et al.
Publicado: (2022)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
por: Reinhard, Henrik, et al.
Publicado: (2011)

Urinary proteome signature of Renal Cysts and Diabetes syndrome in children
por: Ricci, Pierbruno, et al.
Publicado: (2019)

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
por: Hellemons, Merel E., et al.
Publicado: (2011)

Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population
por: Zhang, Zhenyu, et al.
Publicado: (2014)

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes
por: Joergensen, Christel, et al.
Publicado: (2011)

Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Correlation between microalbuminuria and urinary copper in type two diabetic patients
por: Talaei, Afsaneh, et al.
Publicado: (2011)

Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
por: Hovind, Peter, et al.
Publicado: (2009)

Vitamin D Levels and Mortality in Type 2 Diabetes
por: Joergensen, Christel, et al.
Publicado: (2010)

Osteoprotegerin and Mortality in Type 2 Diabetic Patients
por: Reinhard, Henrik, et al.
Publicado: (2010)

Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate
por: Joergensen, Christel, et al.
Publicado: (2012)

The use of urinary proteomics in the assessment of suitability of mouse models for ageing
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2017)

Urinary Proteomics to Support Diagnosis of Stroke
por: Dawson, Jesse, et al.
Publicado: (2012)

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
por: Lajer, Maria, et al.
Publicado: (2010)

Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology
por: Maahs, David M., et al.
Publicado: (2010)

Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2015)

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria
por: Øvrehus, Marius A, et al.
Publicado: (2015)

Microalbuminuria in children with urinary tract infection
por: Kwak, Byung Ok, et al.
Publicado: (2010)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
por: Pontillo, Claudia, et al.
Publicado: (2017)

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study
por: Piazza, M., et al.
Publicado: (2020)

Retinopathy and microalbuminuria in type II diabetic patients
por: Manaviat, Masoud R, et al.
Publicado: (2004)

Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus
por: Sana, Muhammad Ahsan, et al.
Publicado: (2020)

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus
por: Pena, Michelle J., et al.
Publicado: (2016)

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes
por: Mizushige, Tomoko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_grucdqrldl58oj4fho6qudamhc